Use of nocturnal pulsioximetry (POX) to assess the control of CPAP therapy in patients with obstructive sleeping apnea (OSA)
I. Muñoz Ramirez (Cadiz, Spain), R. De Andres David (Cádiz, Spain), A. Ais Daza (Cádiz, Spain), F. Montoro Ballesteros (Cádiz, Spain), A. Marin Andreu (Cádiz, Spain), A. Arnedillo Muñoz (Cádiz, Spain)
Source: International Congress 2022 – Pathophysiological consequences of sleep apnoea: insights from basic research
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Muñoz Ramirez (Cadiz, Spain), R. De Andres David (Cádiz, Spain), A. Ais Daza (Cádiz, Spain), F. Montoro Ballesteros (Cádiz, Spain), A. Marin Andreu (Cádiz, Spain), A. Arnedillo Muñoz (Cádiz, Spain). Use of nocturnal pulsioximetry (POX) to assess the control of CPAP therapy in patients with obstructive sleeping apnea (OSA). 2095
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|